Stephen T. Sonis

Stephen T. Sonis is a prominent researcher and faculty member at Harvard University, where he holds a distinguished position bridging oral medicine and oncology. He earned his dental degree and completed advanced training in oral medicine and pathology, establishing a career dedicated to improving patient outcomes during cancer therapy. Dr. Sonis’s research focuses primarily on the oral complications of cancer treatment, with particular emphasis on oral mucositis—a debilitating side effect of chemotherapy and radiation. His work spans clinical trials, translational research, and health services investigations aimed at preventing, managing, and mitigating treatment-related toxicities. He has led and contributed to numerous high-impact studies, including phase 3 trials evaluating interventions such as avasopasem manganese for severe oral mucositis and innovative cryotherapy delivery systems. Beyond mucosal injury, his recent scholarship also addresses financial toxicity, reimbursement equity in dental care, and clinical trial design in head and neck oncology. With an h-index of 79 and over 460 publications, Dr. Sonis is recognized internationally for advancing supportive care paradigms and enhancing quality of life for cancer patients. His ongoing research continues to shape clinical guidelines and therapeutic strategies in oncology and oral medicine.